BridgeBio Pharma Q3 EPS $(1.08) Misses $(0.81) Estimate, Sales $4.09M Miss $4.26M Estimate
Portfolio Pulse from Benzinga Newsdesk
BridgeBio Pharma reported Q3 losses of $(1.08) per share, missing the analyst consensus estimate of $(0.81) by 33.33%. The company also reported quarterly sales of $4.09 million, missing the estimate of $4.26 million by 3.97%. This represents a 16.13% decrease in losses and a 1.11K% increase in sales compared to the same period last year.
November 02, 2023 | 11:56 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BridgeBio Pharma's Q3 earnings missed estimates, with losses increasing and sales not meeting expectations.
BridgeBio Pharma's Q3 earnings missed analyst estimates, which could negatively impact investor sentiment and potentially lead to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100